In This Article:
FORT MYERS, Fla. (AP) — FORT MYERS, Fla. (AP) — NeoGenomics Inc. (NEO) on Tuesday reported a loss of $25.9 million in its first quarter.
The Fort Myers, Florida-based company said it had a loss of 20 cents per share. Earnings, adjusted for stock option expense and amortization costs, were less than 1 cent on a per-share basis.
The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 2 cents per share.
The operator of cancer-focused testing laboratories posted revenue of $168 million in the period, which did not meet Street forecasts. Seven analysts surveyed by Zacks expected $170.9 million.
NeoGenomics expects full-year earnings in the range of 16 cents to 20 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NEO at https://www.zacks.com/ap/NEO